Development of a New Nanocarrier for Dietary Garcinol: Characterization and In Vitro Efficacy Evaluation Using Breast Cancer Stem Cells Grown in Hypoxia

Table 5

IC₅₀ value of each NP assessed at 24, 48, and 72 h incubations.

Drug/NP	IC50 (µg/mL)
	24 h	48 h	72 h
Garcinol	21.16	17.06	10.22
PTX	49.74	31.85	20.87
GA-NP	10.23	6.049	1.701
HA-GA-NP	5.54	4.03	0.81